Hauser, RA, Salin, L, Juhel, N, Konyago, VL
, Armon, C, Bartel, D, Bohnen, NI, Cleeremans, B, Comella, C, Davidson, W, De Marcaida, JA, Dowel, A, Drasby, E, Evans, B, Fazzini, E, Ferencz, G, Fernandez, H, Friedlander, J, Gazda, S, Guttman, M, Hart, D, Isaacson, S, Jacobs, A, Jankovic, J, Jennings, D, King, D, Kirby, LC, Kohrman, B, Kostyk, S, Liebowitz, MR, Lobatz, M, Margolin, DI, Markopoulou, E, Murphy, JM, McElveen, WA, Ng, CK, Nunez, M, Parashos, SA, Porter, J, Pourcher, E, Rajput, A, Richter, R, Ross, DB, Schwartz, HD, Singer, C, Stevens, J, Stoessl, J, Suchowersky, O, Sutton, JP, Tabbaa, M, Truong, D, Tuite, P, Wallis, RIA, Wendt, J, Zesiewicz, T & Zweig, R 2007, '
Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease',
Movement Disorders, vol. 22, no. 3, pp. 359-365.
https://doi.org/10.1002/mds.21258